DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care
for more than 60 years, presented data about the roles SHARESOURCE
remote patient management platform and AMIA automated peritoneal
dialysis (APD) system are playing in making home dialysis more efficient
and supporting patient independence during the American Society of
Nephrology’s (ASN) annual Kidney Week, Nov. 15-20 in Chicago.
Early data indicate how Baxter’s SHARESOURCE telehealth platform is
helping physicians recognize adverse issues early, enabling faster
treatment (Abstract #PO023); and how Baxter’s AMIA APD system, with
voice-guided, patient-centric features, is helping a clinic
significantly reduce training times by more than one day, per patient
(Abstract #PO1047). In total, Baxter presented 24 abstracts across all
renal modalities during Kidney Week to support scientific exchange
during the meeting and increase the quality of care for patients with
end-stage renal disease (ESRD).
''Data on the use of Baxter’s AMIA APD system and the SHARESOURCE
telehealth platform tell us the technology is enhancing dialysis clinic
efficiencies,'' said Dheerendra Kommala, M.D., vice president, Medical
Affairs, Baxter. ''For the first time, physicians have more reliable
visibility to their patient’s home therapy, which helps them identify
potential clinical and therapy adherence issues sooner so that informed
decisions can be addressed more quickly.''
The Baxter SHARESOURCE platform data was discussed in a case study from
the Geneva University Hospital in Geneva, Switzerland. Healthcare
providers at the hospital offer SHARESOURCE with Baxter’s HOMECHOICE
CLARIA APD system. For one patient, the hospital initially observed no
remote patient management alerts and normal PD cycle volume profiles.
Then, SHARESOURCE conveyed red flag alerts of prolonged drain times for
the patient, which allowed the hospital clinicians to make an early
diagnosis and surgically reposition a displaced catheter. Catheter
malposition and dysfunction is one of the leading causes for dropout
from PD and transfer to hemodialysis (HD)1,2.
Additionally, a simulation study of twelve APD patient profiles suggests
remote management of APD patients through telehealth can save
approximately $22,000 in total healthcare resources (Abstract #PO483).
The study identified saved healthcare resources associated with
treatment non-adherence, fluid overload, missing data and other issues,
enabling earlier medical intervention to help avoid complications and
New data presented on Baxter’s AMIA APD system also indicated how a
clinic was able to provide more efficient training for patients, helping
those on AMIA to go home at least one day sooner than on the legacy APD
system. These conclusions were reached in a retrospective review of
patients on AMIA and the Baxter HOMECHOICE system by the Icahn School of
Medicine, Mount Sinai, Renal Division in New York.
About AMIA and HOMECHOICE CLARIA with SHARESOURCE
AMIA was designed to allow patients to administer their own PD therapy
in the home setting with intuitive features, such as voice guidance, a
touchscreen control panel and the SHARESOURCE remote patient management
platform. AMIA also is up to 40 percent smaller and 30 percent lighter
than other cyclers on the market, and features a folding design when the
touch screen is not in use3,4.
SHARESOURCE allows healthcare providers to securely view their patients’
recently completed home dialysis-related treatment data that is
automatically collected after each PD session. Healthcare providers can
then act on this information by remotely adjusting their patients’ home
device settings without requiring them to travel to the clinic.
AMIA with SHARESOURCE is available in the United States and is currently
being used by more than 1,000 ESRD patients to manage therapy. The
SHARESOURCE remote patient management platform is also available outside
the United States on Baxter’s HOMECHOICE CLARIA system, which is
currently being used by more than 1,300 patients to conduct home
therapy. Baxter’s SHARESOURCE telehealth platform recently reached a
milestone of helping healthcare providers manage about 200,000 PD
treatments performed in patients’ homes with either AMIA or HOMECHOICE
Rx Only. For safe and proper use of the devices mentioned
herein, refer to the complete instructions in the Operator's Manual.
About Baxter International Inc.
Baxter provides a broad portfolio of essential renal and hospital
products, including home, acute and in-center dialysis; sterile IV
solutions; infusion systems and devices; parenteral nutrition;
biosurgery products and anesthetics; and pharmacy automation, software
and services. The company’s global footprint and the critical nature of
its products and services play a key role in expanding access to
healthcare in emerging and developed countries. Baxter’s employees
worldwide are building upon the company’s rich heritage of medical
breakthroughs to advance the next generation of healthcare innovations
that enable patient care.
This release includes forward-looking statements concerning Baxter's
AMIA and HOMECHOICE CLARIA APD systems and the SHARESOURCE remote
patient management platform, including anticipated benefits associated
with their use. The statements are based on assumptions about many
important factors, including the following, which could cause actual
results to differ materially from those in the forward-looking
statements: satisfaction of regulatory and other requirements; actions
of regulatory bodies and other governmental authorities; product
quality, manufacturing or supply issues; patient safety issues; changes
in law and regulations; breaches or failures of the company’s
information technology systems; and other risks identified in Baxter's
most recent filing on Form 10-K and other SEC filings, all of which are
available on Baxter's website. Baxter does not undertake to update its
Baxter, Amia, HomeChoice Claria and Sharesource are registered
trademarks of Baxter International Inc.
1 Kolesnyk, Inna et al. Time-Dependent Reasons for Peritoneal
Dialysis Technique Failure and Mortality. Peritoneal Dialysis
International. 2010. Vol. 30. 170-177.
2 Data on
file, Baxter International, 2016.
3 Amia Automated PD
System Patient Guide. Baxter Healthcare Corporation. Deerfield, IL.
HomeChoice and HomeChoice PRO APD Systems Patient At-Home Guide. Baxter
Healthcare Corporation. Deerfield, IL.